KPSC Staff Nurse - 2018
Mental Health Nursing
Easy

Which of the following is used in drug dependence to prevent relapse?

Appeared in: KPSC Staff Nurse - 2018

Explanation

  • Naltrexone is a competitive opioid antagonist specifically approved for preventing relapse in detoxified individuals with opioid use disorder (OUD) and alcohol use disorder.
  • It works by blocking the opioid receptors, which prevents the euphoric effects ('high') if the person uses opioids or alcohol, thereby reducing the incentive to use.
  • It has a long half-life and is available in both a daily oral form (Revia) and a once-a-month injectable form (Vivitrol), making it suitable for long-term maintenance therapy.
  • Unlike naloxone, which is for emergency overdose reversal, naltrexone's pharmacological profile is designed for sustained relapse prevention.

Why Other Options Were Wrong

  • Option A: Naloxone is a very short-acting opioid antagonist. Its rapid onset and short duration (30-90 minutes) make it ideal for reversing an acute opioid overdose but unsuitable for long-term relapse prevention, as it would require frequent, impractical dosing.
  • Option C: Neuroleptics, also known as antipsychotics, are used to manage symptoms of psychosis, such as hallucinations and delusions. They do not act on opioid receptors and have no primary role in preventing relapse in substance dependence.
  • Option D: Nomifensine is an old antidepressant medication that was withdrawn from the market in many countries due to its risk of serious side effects, including hemolytic anemia. It is not used for any clinical purpose today, especially not for addiction.

Related Visual

Visual explanation — Related Visual
Clinical Relevance
  • Nursing practice connection: Knowing Pharmacological management of substance dependence for relapse prevention helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
  • A critical nursing responsibility is educating the patient that they must be completely opioid-free before starting naltrexone. Failure to do so will trigger a severe, painful, and dangerous precipitated withdrawal syndrome.
  • Nurses must monitor liver function tests (LFTs) before and during naltrexone therapy, as it carries a risk of hepatotoxicity, especially in patients with pre-existing liver disease.
  • Patient education should also include the fact that naltrexone will block the effects of opioid-based pain medications, which is a crucial consideration for future pain management. Patients should be advised to carry a medical alert card.
How to Approach the Question
  • First, identify the key goal in the question stem: 'prevent relapse' in 'drug dependence'. This points to a long-term maintenance medication, not an emergency treatment.
  • Next, analyze the options based on their drug class and primary indication.
  • Recall or look up that Naloxone is a short-acting antagonist for overdose reversal.
  • Recall or look up that Naltrexone is a long-acting antagonist used for relapse prevention.
  • Recognize that 'Neuroleptic' is a term for antipsychotics, which are used for psychosis, not addiction relapse.
  • Eliminate Nomifensine as it is an obsolete drug.
Concept Tested & Keywords
  • Concept Tested: Pharmacological management of substance dependence for relapse prevention.
  • Stem keywords: drug dependence, prevent relapse
  • Lead-in keywords: Which
  • Negative lead-in flag: false

Question ID

QSX6mn69T1oIk0QaOrMVAV

Reference Book

E6 Kaplan Sadock's Synopsis of Psychiatry-2022 (pp 1-3768 of 3768) p. 2173-2175

E6 Robert Boland, Marcia L. Verduin - Kaplan and Sadock's Comprehensive Text of Psychiatry-Wolters Kluwer Health (2024) (pp 1-16525 of 16525) pp. 10898-10900, 10930-10932

Practise the full KPSC Staff Nurse - 2018

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Substance Use Disorders Questions

More KPSC Staff Nurse - 2018 Questions